European Bioinformatics Institute

What European Bioinformatics Institute does

EMBL-EBI (European Bioinformatics Institute) is one of six sites of the European Molecular Biology Laboratory (EMBL), an intergovernmental organization founded in 1974 and headquartered in Heidelberg, Germany. EMBL-EBI was established in 1992 at the Wellcome Genome Campus in Hinxton, Cambridgeshire, UK, with 501–1000 employees. Its mission is to provide open, freely accessible molecular biology data infrastructure to the global life science research community; it operates 45 data resources spanning genomes and metagenomes, nucleotide and protein sequences, gene expression, molecular interactions, pathways, protein structures, gene-disease associations, literature, and samples. Flagship resources include AlphaFold DB (over 200 million predicted protein structures, built with Google DeepMind), the European Nucleotide Archive (part of the INSDC), UniProt (delivered via the UniProt Consortium), the GWAS Catalog, BioImage Archive, and Europe PMC, all accessible via web portals, REST APIs, and FTP.

The platform's underlying technology combines decades of expert-curated biological data with increasingly AI-augmented pipelines: deep learning for protein structure prediction, NLP/LLM-based text mining (notably the open-source BioChatter framework) for patent and literature curation, computer vision for bioimage analysis through the BioImage Model Zoo, and predictive analytics via the CORNETO multi-omics tool and emerging digital twins for rare diseases. EMBL-EBI is governed and funded by over 20 European member states through EMBL membership contributions, supplemented by research grants and an Industry Programme that offers pre-competitive collaboration and knowledge exchange to bioindustry partners.

The business model is non-commercial at its core: all 45 data resources are provided free of charge under CC0, CC-BY, or Terms of Use, with 68% of resources using maximally permissive Terms of Use or CC0 licensing as of 2024. Distribution is entirely digital and self-service — web portals, REST APIs, and FTP downloads — without a traditional sales function. The Industry Programme generates some revenue through membership and structured collaboration, and the institute supports training, events, and webinars as content-led community engagement. Primary customer segments are life science researchers in academia and industry, bioindustry companies participating in pre-competitive consortia, and bioinformatics trainees; an independent 2021 study estimated that EMBL-EBI's open data resources generate up to £11 billion in equivalent annual financial return to the scientific community.

Name

European Bioinformatics Institute

Legal name

EMBL-EBI (European Bioinformatics Institute)

Website

https://ebi.ac.uk

Company type

Private

Founded year

1974

Operating status

Operating

Headcount range

501–1,000 employees

Short description

EMBL-EBI is a UK-based intergovernmental bioinformatics institute, part of EMBL, that operates 45 freely accessible molecular biology data resources — including AlphaFold DB, UniProt, ENA, GWAS Catalog, and Europe PMC — serving the global life science research community via open access, APIs, and training, funded by 20+ European member states.

Ownership category

akta.pro rank

Product category

Bioinformatics Data Infrastructure

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714), Research and Development in the Physical, Engineering, and Life Sciences (54171), Web Search Portals, Libraries, Archives, and Other Information Services (5192)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Bioinformatics & Multi-omics Analysis Software (HLAGAJAD)

Keywords

• Biological data resources
• Bioinformatics databases
• Protein structure prediction
• Genome annotation services
• Molecular data infrastructure

Headquarters

HQ city

Hinxton

HQ country

United Kingdom

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Infrastructure, Operations

Revenue model

1. Government Funding: EMBL-EBI is funded through EMBL membership contributions from over 20 European member states. The institute operates as an intergovernmental organization providing open access to biological data without commercial revenue generation.
2. Industry Partnerships: The Industry Programme offers membership and collaboration opportunities for companies making significant use of EMBL-EBI data resources, providing pre-competitive collaborations and knowledge exchange.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels5 records

Core offering

EMBL-EBI maintains the world's most comprehensive range of freely available molecular data resources and analysis tools for life science research. It provides open-access databases covering nucleotide sequences, protein sequences and structures, genome annotations, gene expression, molecular interactions, pathways, and scientific literature. Resources are delivered via web portals, REST APIs, and FTP downloads for researchers worldwide.

Product overview

EMBL-EBI operates a comprehensive platform of freely available biological data resources and analysis tools that serve as the world's most extensive molecular data infrastructure. The portfolio includes major databases such as Ensembl (genome annotations), European Nucleotide Archive (nucleotide sequences), UniProt (protein sequences), Reactome (pathways), IntAct (molecular interactions), PDBe (protein structures), ChEMBL (bioactive compounds), Europe PMC (literature), and specialized resources like the BioImage Archive (biological imaging data), AlphaFold DB (protein structures), GWAS Catalog (genetic associations), PRIDE (proteomics), and MetaboLights (metabolomics). The platform provides web APIs for programmatic access to enable computational biology workflows. EMBL-EBI also supports training programs and maintains international collaborations with major database partners including NCBI, DNA Databank of Japan, Swiss Institute of Bioinformatics, and others to ensure global data preservation and accessibility.

Differentiator

Problem solved

Functional benefit

Products and services

• AlphaFold DB Database providing computationally predicted 3D protein structures for numerous species, hosting over 200 million predicted protein structures. Developed in collaboration with Google DeepMind; designed for life science researchers and drug discovery teams.
• GWAS Catalog Quality-controlled, manually curated, literature-derived collection of all published genome-wide association studies, linking genetic variants to traits and diseases. Used by researchers in genomics and genetic epidemiology.
• International Genome Sample Resource Deep catalog of shared human genetic variation in population groups worldwide, derived from the 1000 Genomes Project. Serves population genetics researchers worldwide.
• UniProt ID Mapping Service for mapping protein identifiers to or from UniProtKB, enabling interoperability between different protein database identifier systems. Used by bioinformaticians and computational biologists.
• Annotare Submission tool for functional genomics data to the ArrayExpress Collection within the BioStudies database. Supports standardized data deposition workflows for researchers.
• Annotation Platform Platform consolidating text-mined and curated annotations from scientific literature, providing standardized biological annotations for research use.
• EMBL-EBI Data Resources Portfolio Portfolio of over 45 freely available biological data resources covering genomes, nucleotide sequences, protein sequences, small molecules, gene expression, molecular interactions, pathways, protein families, literature, and samples. Core resources include Ensembl, European Nucleotide Archive, UniProt, Reactome, IntAct, PDBe, ChEMBL, Europe PMC, BioImage Archive, PRIDE, and MetaboLights.

Quantifiable outcome

• £11 billion annual equivalent financial return from open data resources (2021 independent report)
• +2 more outcomes

Named customers4 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

Yes

API docs

API detail

Core technology

AI maturity

App detail

AI capability9 records

Feature8 records

Partnerships

Twelve partnerships are on record, tiered core.

• Open TargetscoreStrategic or Co-development Partner · 1 March 2026Joint initiative developing digital twins for rare diseases using multi-omics, clinical, and real-time physiological data. Funded by Chan Zuckerberg Initiative. EMBL-EBI researchers are actively involved in developing computational approaches for patient biology simulations.
• NVIDIAcoreTechnology or IntegrationExpanded AlphaFold Protein Structure Database partnership with Google DeepMind and EMBL, with NVIDIA BioNeMo platform integrated for genomic analysis. NVIDIA announced expanded collaboration at GTC 2026 conference.
• Google DeepMindcoreStrategic or Co-development PartnerDeep collaboration on AlphaFold protein structure prediction system and AlphaFold Database hosting over 200 million predicted protein structures at EMBL-EBI.
• International Nucleotide Sequence Database Collaboration (INSDC)coreTechnology or IntegrationENA data mirrored by NCBI (GenBank) and DNA Databank of Japan ensuring distributed delivery and data preservation across international partners.
• UniProt ConsortiumcoreTechnology or IntegrationUniProt delivered in partnership with Protein Information Resource (Georgetown University, University of Delaware) and Swiss Institute of Bioinformatics.
• Worldwide Protein Data Bank (wwPDB)coreTechnology or IntegrationPDBe operates as a partner in wwPDB alongside Research Collaboratory for Structural Bioinformatics (US), PDBj (Japan), and BioMagResBank (US).
• IMEx ConsortiumcoreTechnology or IntegrationInternational molecular interaction database consortium ensuring consistent annotation and exchange of interaction data.
• ProteomeXchange ConsortiumcoreTechnology or IntegrationInternational proteomics data sharing consortium coordinated through EMBL-EBI's PRIDE resource.
• ELIXIRcoreTechnology or IntegrationEMBL-EBI operates as an ELIXIR node supporting coordination of biological data provision throughout Europe across 20+ countries.
• PubMed Central InternationalcoreTechnology or IntegrationEurope PMC operates as part of PubMed Central International with PMC (NCBI, US) and PubMed Central Canada ensuring global literature access.
• Wellcome Sanger InstitutecoreStrategic or Co-development PartnerCollaborates on Ensembl genome annotation, WormBase, Vega, GeneDB, and other major database projects at Wellcome Genome Campus.
• RNAcentral ConsortiumcoreTechnology or IntegrationInternational consortium integrating non-coding RNA databases including Rfam, PDBe, ENA, and 20+ partner databases worldwide.

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

Others

• Genome Reference Consortium (GRC): Maintains the human reference genome assembly with contributions from EMBL-EBI (via Ensembl), NCBI, and Sanger. GRC is a closely adjacent standards-setting consortium rather than a directly competitive operator.
• ELIXIR: European bioinformatics coordination infrastructure in which EMBL-EBI operates as the UK node. ELIXIR is an ecosystem/standards organization rather than a direct competitor, but is thematically comparable as a public bioinformatics coordination body.
• Open Targets: Public-private partnership co-led by EMBL-EBI that uses EMBL-EBI's data resources for drug target identification and prioritization. Open Targets is an enabling ecosystem partner rather than a competitor.

Direct peers

• Swiss Institute of Bioinformatics (SIB): Co-delivers UniProt with EMBL-EBI and operates its own portfolio of bioinformatics resources including Expasy, STRING, and Swiss-Prot. SIB is a closely comparable European public bioinformatics institute with overlapping resources and a similar non-profit, public-good model.
• Berman lab / Worldwide Protein Data Bank (wwPDB): Manages the global Protein Data Bank archive with EMBL-EBI's PDBe as a partner site. wwPDB is directly comparable as a public, internationally distributed macromolecular structure data resource.
• National Center for Biotechnology Information (NCBI): Operates GenBank and mirrors EMBL-EBI's European Nucleotide Archive (ENA) via the INSDC partnership. NCBI is the closest direct peer, providing overlapping open-access genomic and literature databases (PubMed) to a global scientific audience.
• DNA Data Bank of Japan (DDBJ): Japanese counterpart and INSDC partner that mirrors ENA nucleotide sequence data. DDBJ operates a comparable national bioinformatics data infrastructure with similar open-access mission and international consortium participation.

Broad incumbents

• Broad Institute: Major US genomics and bioinformatics institute operating gnomAD, the Terra platform, and Cellosaurus. Broad is a broader biomedical research institute but is comparable as a public-facing, large-scale genomics and computational biology organization.
• Wellcome Sanger Institute: Co-located at the Wellcome Genome Campus in Hinxton and a major collaborator on Ensembl and other genome resources. Sanger is a broader genomics research institute with deeper sequencing and wet-lab capabilities but overlapping bioinformatics/data mandate.

Regional players

• National Human Genome Research Institute (NHGRI): Co-funds the GWAS Catalog with EMBL-EBI. NHGRI is a US federal genomics research agency with overlapping mandate to advance genomic data resources but operates primarily as a funder/policy body rather than a direct data-hosting peer.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/ebi
• Xx.com/emblebi
• Facebookfacebook.com/EMBLEBI

Revenue estimate

Valuation estimate

Number of profiles

Profiles10 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about European Bioinformatics Institute